However, dysregulated IL-17A expression is strongly linked to several human diseases, such as multiple sclerosis (MS), psoriasis, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and asthma (2). Here, IL17A is linked to myeloid sarcoma.